Goldman Sachs’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-501,164
| Closed | -$5.2M | – | 6831 |
|
|
2022
Q2 | $5.2M | Buy |
501,164
+36,172
| +8% | +$269K | ﹤0.01% | 3092 |
|
|
2022
Q1 | $4.11M | Buy |
464,992
+81,431
| +21% | +$617K | ﹤0.01% | 3532 |
|
|
2021
Q4 | $2.65M | Sell |
383,561
-288,025
| -43% | -$4.23M | ﹤0.01% | 3996 |
|
|
2021
Q3 | $8.33M | Buy |
671,586
+114,585
| +21% | +$1.65M | ﹤0.01% | 2894 |
|
|
2021
Q2 | $10.2M | Buy |
557,001
+86,028
| +18% | +$1.71M | ﹤0.01% | 2675 |
|
|
2021
Q1 | $9.82M | Sell |
470,973
-66,561
| -12% | -$1.4M | ﹤0.01% | 2580 |
|
|
2020
Q4 | $9.6M | Sell |
537,534
-450,742
| -46% | -$6.77M | ﹤0.01% | 2504 |
|
|
2020
Q3 | $11.2M | Buy |
988,276
+4,697
| +0.5% | +$58K | ﹤0.01% | 2221 |
|
|
2020
Q2 | $13.4M | Buy |
983,579
+64,691
| +7% | +$891K | ﹤0.01% | 2025 |
|
|
2020
Q1 | $11.9M | Buy |
918,888
+68,544
| +8% | +$1.22M | ﹤0.01% | 1934 |
|
|
2019
Q4 | $17.1M | Buy |
850,344
+148,686
| +21% | +$3.61M | ﹤0.01% | 1997 |
|
|
2019
Q3 | $18.1M | Buy |
701,658
+171,800
| +32% | +$4.21M | 0.01% | 1863 |
|
|
2019
Q2 | $12.9M | Buy |
529,858
+157,311
| +42% | +$3.44M | ﹤0.01% | 2184 |
|
|
2019
Q1 | $7.43M | Sell |
372,547
-137,687
| -27% | -$2.51M | ﹤0.01% | 2670 |
|
|
2018
Q4 | $8.41M | Buy |
510,234
+257,175
| +102% | +$4.33M | ﹤0.01% | 2465 |
|
|
2018
Q3 | $4.5M | Sell |
253,059
-27,197
| -10% | -$615K | ﹤0.01% | 3064 |
|
|
2018
Q2 | $8.26M | Buy |
280,256
+72,151
| +35% | +$2.28M | ﹤0.01% | 2558 |
|
|
2018
Q1 | $7.48M | Sell |
208,105
-71,960
| -26% | -$2.6M | ﹤0.01% | 2588 |
|
|
2017
Q4 | $8.9M | Buy |
280,065
+142,741
| +104% | +$4.48M | ﹤0.01% | 2546 |
|
|
2017
Q3 | $5.29M | Sell |
137,324
-32,725
| -19% | -$1.28M | ﹤0.01% | 3083 |
|
|
2017
Q2 | $7.69M | Sell |
170,049
-37,824
| -18% | -$1.45M | ﹤0.01% | 2717 |
|
|
2017
Q1 | $8.03M | Buy |
207,873
+14,827
| +8% | +$622K | ﹤0.01% | 2558 |
|
|
2016
Q4 | $7.34M | Sell |
193,046
-239,670
| -55% | -$11.4M | ﹤0.01% | 2710 |
|
|
2016
Q3 | $23.4M | Buy |
432,716
+28,663
| +7% | +$1.46M | 0.01% | 1772 |
|
|
2016
Q2 | $14.8M | Sell |
404,053
-12,219
| -3% | -$431K | ﹤0.01% | 2013 |
|
|
2016
Q1 | $13.1M | Sell |
416,272
-16,917
| -4% | -$585K | ﹤0.01% | 2028 |
|
|
2015
Q4 | $26.7M | Buy |
433,189
+220,122
| +103% | +$13.9M | 0.01% | 1544 |
|
|
2015
Q3 | $14.8M | Buy |
213,067
+192,685
| +945% | +$13.4M | 0.01% | 1939 |
|
|
2015
Q2 | $1.38M | Sell |
20,382
-6,464
| -24% | -$301K | ﹤0.01% | 4223 |
|
|
2015
Q1 | $1.1M | Sell |
26,846
-6,766
| -20% | -$304K | ﹤0.01% | 4362 |
|
|
2014
Q4 | $1.31M | Sell |
33,612
-3,360
| -9% | -$79.7K | ﹤0.01% | 4273 |
|
|
2014
Q3 | $776K | Buy |
+36,972
| New | +$499K | ﹤0.01% | 4870 |
|
Other funds holding RDUS
Goldman Sachs's RDUS Position: Q3 2022 in Review
Goldman Sachs sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 501,164 shares — an estimated $5.2M sold.
Goldman Sachs first reported a position in RDUS in Q3 2014 and held it in 32 quarters. The position peaked at $26.7M in Q4 2015. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Goldman Sachs reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Goldman Sachs sold 501,164 Radius Health, Inc. shares in Q3 2022, an estimated $5.2M.
- Goldman Sachs first reported a position in Radius Health, Inc. in Q3 2014 and held it in 32 quarters.
- Goldman Sachs's Radius Health, Inc. position peaked at $26.7M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.